Právní předpis byl sestaven k datu 12.12.2025.
Zobrazené znění právního předpisu je účinné od 12.12.2025.
Sdělení Ministerstva zdravotnictví o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2026
528/2025 Sb.
528
XXXXXXX
Xxxxxxxxxxxx zdravotnictví
ze xxx 10. prosince 2025
x xxxxxxxxxx složení xxxxxxxxxx xxxxx xxx xxxxxxxxxx, xxxxxxxx a xxxxxxxxx xxxxxxxx pro rok 2026
&xxxx;
Xxxxxxxxxxxx zdravotnictví xxxxx §80 odst. 1 xxxx. x) xxxxxx x. 258/2000 Sb., x ochraně veřejného xxxxxx x x xxxxx některých xxxxxxxxxxxxx xxxxxx, xx znění xxxxxxxxxx předpisů, xxxxxxx xx základě xxxxxxxxxx Xxxxxxx xxxxxxxxxx xxxxxx xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx pro xxxxxxxxxx, xxxxxxxx x mimořádná xxxxxxxx pro xxx 2026:
1.&xxxx;Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx pravidelná xxxxxxxx
1x) kombinovaná očkovací xxxxx xxxxx záškrtu, dávivému xxxxx (xxxxxxxxxx forma), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx), xxxxxx hepatitidě X, xxxxxxx xxxxxxxxx Haemophilus xxxxxxxxxx typ x (XXxXXxxXXXXXX)
Xx rekonstituci 1 xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx anatoxinum1 ne xxxx xxx 30 xxxxxxxxxxxxx xxxxxxxx (IU)
Tetani xxxxxxxxxx1&xxxx;xx xxxx xxx 40 xxxxxxxxxxxxx xxxxxxxx (XX)
Xxxxxxxx&xxxx;Xxxxxxxxxx xxxxxxxxx:
Xxxxxxxxx xxxxxxxxxx (XX)1&xxxx;25 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxxx filamentosum (XXX)1&xxxx;25 xxxxxxxxxx
Xxxxxxxxxxx (PRN)1 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X (HBs)2,3 10 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx (XXX)
xxxxx 1 (kmen Mahoney)4 40 X xxxxxxxx xxxxxxxx
xxxxx 2 (xxxx MEF-1)4 8 X xxxxxxxx xxxxxxxx
xxxxx 3 (xxxx Saukett)4 32 X xxxxxxxx antigenu
Haemophilus xxxxxxxxxx xxxxx&xxxx;x xxxxxxxxxxxxxxx
(Xxxxxxxxxxxxxxxxxxx xxxxxxxx) 10 mikrogramů
conj. xxx anatox. tetanico xxxx xxxxx xxxxxxx xxxxxxxxx 25 mikrogramů
1 adsorbováno xx xxxxxxxx hlinitý, xxxxxxxxxxx (Al(OH)3) 0,5 xxxxxxxxx Xx3+
2&xxxx;xxxxxxxx rekombinantní XXX technologií xx xxxxxxx kvasinkových xxxxx (Xxxxxxxxxxxxx cerevisiae)
3 adsorbováno na xxxxxxxxxxx xxxxxxx (XxXX4) 0,32 xxxxxxxxx Xx3+
4&xxxx;xxxxxxxxx xx VERO xxxxxxx
XXXX
1xx)&xxxx;xxxxxxxxxxx xxxxxxxx xxxxx xxxxx xxxxxxx, dávivému kašli (xxxxxxxxxx forma), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx), xxxxxx xxxxxxxxxx X, xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx x (XXxXXxxXXXXXX)
Xxxxx xxxxx1&xxxx;(0,5 ml) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx xx xxxx xxx 20 xxxxxxxxxxxxx xxxxxxxx (IU)2,4 (30 Xx)
Xxxxxx xxxxxxxxxx xx xxxx xxx 40 mezinárodních xxxxxxxx (IU)3,4 (10 Xx)
Xxxxxxxx Xxxxxxxxxx pertussis
Pertussis xxxxxxxxxx 25 xxxxxxxxxx
Xxxxxxxxx haemagglutininum xxxxxxxxxxxx 25 xxxxxxxxxx
Xxxxx Xxxxxxxxxxxxxxx (xxxxxxxxxxxx)5
xxxxx 1 (Xxxxxxx) 29 X xxxxxxxx xxxxxxxx6
xxxxx 2 (XXX-1) 7 X xxxxxxxx xxxxxxxx6
xxxxx 3 (Xxxxxxx) 26 X xxxxxxxx antigenu6
Tegiminis xxxxxxxxxxx X xxxxxxxxx7&xxxx;10 xxxxxxxxxx
Xxxxxxxxxx xxxxxxxxxx xxxx B xxxxxxxxxxxxxxx (Xxxxxxxxxxxxxxxxxxx phosphas) 12 xxxxxxxxxx
xxxxxxxxxx xxx xxxxxx xxxxxxxx 22-36 xxxxxxxxxx
1&xxxx;Xxxxxxxxxxx na hydratovaný xxxxxxxx hlinitý (0,6 xx Xx3+)
2&xxxx;Xxxx spodní xxx xxxxxxxxxxxxx (x = 0,95) x xx xxxx xxx 30 XX xxxx xxxxxxx xxxxxxx
3&xxxx;Xxxx xxxxxx xxx xxxxxxxxxxxxx (x = 0,95)
4&xxxx;Xxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxxxxxxxxx
5&xxxx;Xxxxxxxxxxx na Xxxx xxxxxxx
6&xxxx;Xxxx množství antigenu xxxx úplně xxxxxx xxxx ta, která xxxx xxxxx vyjádřená xxxx 40-8-32 D xxxxxxxx xxxxxxxx xxx xxxxx xxxx 1, 2 a 3, xxx xxxxxx xxxxx xxxxxxx xxxxxxxxxxxxxx xxxxxxx.
7&xxxx;xxxxxxxx xxxxxxxxxxxxx XXX xxxxxxxxxxx x kvasinkových xxxxxxx Xxxxxxxxx polymorpha
NEBO
1ab) Vakcína xxxxx xxxxxxx, xxxxxx, xxxxxxxx kašli (xxxxxxxxxx xxxxxxxxxx), xxxxxxxxxx X (xXXX), xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx) a xxxxxxxxxxx vakcína xxxxx Xxxxxxxxxxx typu x (xxxxxxxxxxx)
Xxxxx dávka (0,5 xx) obsahuje:
Diphtheriae xxxxxxxxxx1 xx xxxx xxx 20 XX6
Xxxxxx anatoxinumˡ xx méně než 40 XX6
Xxxxxxxx&xxxx;Xxxxxxxxxxx xxxxxxxx1
Xxxxxxxxx xxxxxxxxxx (XX) 20 xxxxxxxxxx
Xxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX) 20 xxxxxxxxxx
Xxxxxxxxxxx (PRN) 3 xxxxxxxxxx
Xxxxxxxx typi 2 xx 3 (XXX) 5 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxx hepatitidis X2,3&xxxx;10 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx (inactivatum)4
Typus 1 (Mahoney) 40 X xxxxxxxx antigenu5
Typus 2 (MEF-1) 8 X xxxxxxxx xxxxxxxx5
Xxxxx 3 (Saukett) 32 X jednotek antigenu5
Polysaccharidi Xxxxxxxxxx xxxxxxxxxx&xxxx;xxxxx b
(Polyribosylribitoli xxxxxxxx) 3 xxxxxxxxxx xxxxxxxxxx xxx xxxxxxxxx xxxxxxxxxxxx typus x2&xxxx;50 xxxxxxxxxx
1&xxxx;xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxx (0,17 xx Xx3+)
2&xxxx;xxxxxxxxxxx na xxxxxxxxxxx xxxxxxxx xxxxxxx xxxxxx (0,15 xx Xx3+)
3&xxxx;xxxxxxxx xxxxxxxxxxxxx XXX xxxxxxxxxxx x xxxxxxxxxxxx buňkách Saccharomyces xxxxxxxxxx
4&xxxx;xxxxxxxxx xx Xxxx xxxxxxx
5&xxxx;xxxx ekvivalentní xxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx xxxxxxx.
6&xxxx;xxxx xxxxxxxxxxxx xxxxxxxx stanovená vyhodnocením xxxxxxxxxxx
1x) xxxxxxxx látka xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx (XXxX)
Xxxxx xxxxx (0,5 xx) xxxxxxxx xxxx xxxxxx xxxxx:
Xxxxxxxxxxx xxxxxxxxxx* ≥ 30 XX
Xxxxxx xxxxxxxxxx* ≥ 40 XX
Xxxxxxxxx xxxxxxxxxx* (XX) 25 mikrogramů
Pertussis xxxxxxxxxxxxxxx xxxxxxxxxxxx* (XXX) 25 xxxxxxxxxx
Xxxxxxxxxxx* (69kD) 8 xxxxxxxxxx
* adsorbováno xx xxxxxxxx xxxxxxx xxxxxx: 0,5 xxxxxxxxx
XXXX
1xx) Xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxx x xxxxxxxx kašli (xxxxxxxxxx) xx xxxxxxxx obsahem xxxxxxxx (Tdap)
Jedna xxxxx (0,5 ml) obsahuje:
Diphtheriae xxxxxxxxxx - Minimálně 2 XX* (2 Xx)
Xxxxxx anatoxinum - Xxxxxxxxx 20 XX* (5 Lf)
Pertusové xxxxxxxx
Xxxxxxxxx xxxxxxxxxx - 2,5 xxxxxxxxxx
Xxxxxxxxxxxxxx filamentosum - 5 xxxxxxxxxx
Xxxxxxxxxxx - 3 xxxxxxxxxx
Xxxxxxxx, xxxx 2 et 3 - 5 xxxxxxxxxx
Xxxxxxxxxxx xx xxxxxxxxxxx hlinitý - 1,5 mg (0,33 xx xxxxxxx)
* Xxxx xxxxxx xxxxxxx xxxxxxxxx spolehlivosti (p = 0,95) xxxxxxxx xxxxxx podle xxxxx xxxxxxxxx v Xxxxxxxxx xxxxxxxx.
XXXX
1xx) Xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxx x xxxxxxxx xxxxx (xxxxxxxxxx komponenta) xx xxxxxxxx xxxxxxx xxxxxxxx (Xxxx)
Xxxxx xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx1&xxxx;xx xxxx než 2 xxxxxxxxxxx xxxxxxxx (IU) (2,5 Xx)
Xxxxxx anatoxinum1 ne xxxx než 20 xxxxxxxxxxxxx xxxxxxxx (XX) (5 Xx)
Xxxxxxxxxxx xxxxxxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxxx1&xxxx;8 mikrogramů
Pertussis xxxxxxxxxxxxxx filamentosum1 8 mikrogramů
Pertactinum1 2,5 xxxxxxxxxx
1&xxxx;xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxxx xxxxxxx (Xx(XX)3) 0,3 miligramů Xx3+&xxxx;x xxxxxxxxxxx hlinitý (AlPO4) 0,2 miligramů Xx3+
1x) xxxxxxxx xxxxx xxxxx xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx typ x:
Xx xxxxxxxxxxxx 1 dávka (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx xxxxx b xxxxxxxxxxxxxxx 10 xxxxxxxxxx
xxxxxxxxxxx x xxxxxxxxxx xxxxxxxx xxxx xxxxxxxxxxx xxxxxxx xxxxxxxxx 25 xxxxxxxxxx
1x) xxxxxxxx látka xxxxx xxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxx xxxxxxxxxx - xxx. 40 mezinárodních xxxxxxxx
1x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx B x xxxxxx formuli:
Jedna xxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X - 10 mikrogramů
1f) očkovací xxxxx proti virové xxxxxxxxxx B v xxxxxxx xxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X - 20 xxxxxxxxxx
1x) xxxxxxxx xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx:
1 dávka xxxxxxxxxxxxxxx vakcíny (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx virus xxxxxxxxxx1&xxxx;(Xxxxxxx) xxx. 103,0 infekční xxxxx xxx xxxxxxxx xxxxxxx503
Xxxxxxxxxxx xxxxx xxxxxxxxxx1&xxxx;(XXX 4385) xxx. 103,7&xxxx;xxxxxxxx xxxxx pro xxxxxxxx xxxxxxx503
Xxxxxxxx virus xxxxxxxxxx2&xxxx;(Xxxxxx XX 27/3) min. 103,0&xxxx;xxxxxxxx xxxxx pro xxxxxxxx kulturu503
1 pomnoženo xx xxxxxxx xxxxxxxx xxxxxx
2&xxxx;xxxxxxxxx xx xxxxxxxx xxxxxxxxxxx xxxxxxx (XXX-5)
3&xxxx;50% xxxxxxxx xxxxx xxxxxxx xxxxxxx
XXXX
1xx) xxxxxxxx xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx
Xx xxxxxxxxxx obsahuje xxxxx xxxxx (0,5 xx):
Xxxxx morbillorum1 vivum xxxxxxxxxx (xxxx Xxxxxx’ Xxxxxxxxx) xx méně než 1x103&xxxx;XXXX50*
Xxxxx xxxxxxxxxxx1&xxxx;xxxxx xxxxxxxxxx (xxxx Jeryl Xxxx™, xxxxxxx X) ne xxxx xxx 12,5x103&xxxx;XXXX50*
Xxxxx xxxxxxxx2&xxxx;xxxxx xxxxxxxxxx (kmen Xxxxxx RA 27/3) xx xxxx xxx 1x103&xxxx;XXXX50*
* 50 % xxxxxxxx xxxxx buněčné xxxxxxx
1&xxxx;xxxxxxxx xx buňkách xxxxxxxx embryí.
2 vyrobeno na xxxxxxxx xxxxxxxxxxx plicních XX-38 fibroblastech.
1h) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxx obrně v xxxxxxxxxxxx xxxxx:
Xxxxx xxxxx (0,5 ml) obsahuje:
Virus xxxxxxxxxxxxx inactivatum xxxxx 1 (Xxxxxxx) ….. 29 xxxxxxxxxxx X xxxxxxxx**
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 2 (XXX-1) ……... 7 xxxxxxxxxxx X xxxxxxxx**
Xxxxx poliomyelitis xxxxxxxxxxx xxxxx 3 (Xxxxxxx) ……. 26 xxxxxxxxxxx D jednotek**
* Kultivováno xx XXXX buňkách
** Tato xxxxxxxx antigenu xxxx xxxxx stejná xxxx xx, xxxxx xxxx xxxxx xxxxxxxxx jako 40-8-32 D jednotek xxxxxxxx xxx xxxxx xxxx 1, 2 x 3, xxx xxxxxx jinou xxxxxxx xxxxxxxxxxxxxx metodou.
1ch) konjugovaná xxxxxxxx látka xxxxx xxxxxxxxxxxxx xxxxxxxx
Xxxxx xxxxx (0,5 ml) obsahuje:
Polysacharid xxxxxxxx (xxxxxxxxxx)&xxxx;Xxxxxxxxxxxxx xxxxxxxxxx&xxxx;xxxxxxxx 11,2&xxxx;2,2 μg
polysacharid xxxxxxxx (xxxxxxxxxx)&xxxx;Xxxxxxxxxxxxx xxxxxxxxxx&xxxx;xxxxxxxx 31,2&xxxx;2,2 μx
xxxxxxxxxxxx bakterie (xxxxxxxxxx)&xxxx;Xxxxxxxxxxxxx xxxxxxxxxx&xxxx;xxxxxxxx 41,2&xxxx;2,2 μx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx)&xxxx;Xxxxxxxxxxxxx xxxxxxxxxx&xxxx;xxxxxxxx 51,2&xxxx;2,2 μx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx)&xxxx;Xxxxxxxxxxxxx pneumoniae sérotypu 6X1,2&xxxx;2,2 μx
xxxxxxxxxxxx xxxxxxxx (pneumokoka) Streptococcus xxxxxxxxxx&xxxx;xxxxxxxx 6X1,2&xxxx;4,4 μx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx)&xxxx;Xxxxxxxxxxxxx xxxxxxxxxx&xxxx;xxxxxxxx 7X1,2&xxxx;2,2 μx
xxxxxxxxxxxx bakterie (xxxxxxxxxx)&xxxx;Xxxxxxxxxxxxx xxxxxxxxxx&xxxx;xxxxxxxx 81,2&xxxx;2,2 μx
xxxxxxxxxxxx bakterie (xxxxxxxxxx)&xxxx;Xxxxxxxxxxxxx xxxxxxxxxx&xxxx;xxxxxxxx 9X1,2&xxxx;2,2 μx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx)&xxxx;Xxxxxxxxxxxxx xxxxxxxxxx&xxxx;xxxxxxxx 10X1,2&xxxx;2,2 μx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx)&xxxx;Xxxxxxxxxxxxx xxxxxxxxxx&xxxx;xxxxxxxx 11X1,2&xxxx;2,2 μx
xxxxxxxxxxxx xxxxxxxx (pneumokoka) Streptococcus xxxxxxxxxx&xxxx;xxxxxxxx 12X1,2&xxxx;2,2 μx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx)&xxxx;Xxxxxxxxxxxxx xxxxxxxxxx&xxxx;xxxxxxxx 141,2&xxxx;2,2 μx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx)&xxxx;Xxxxxxxxxxxxx xxxxxxxxxx&xxxx;xxxxxxxx 15B1,2 2,2 μx
xxxxxxxxxxxx xxxxxxxx (pneumokoka) Streptococcus xxxxxxxxxx&xxxx;xxxxxxxx 18C1,2 2,2 μg
polysacharid xxxxxxxx (xxxxxxxxxx)&xxxx;Xxxxxxxxxxxxx xxxxxxxxxx&xxxx;xxxxxxxx 19X1,2&xxxx;2,2 μx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx)&xxxx;Xxxxxxxxxxxxx pneumoniae sérotypu 19F1,2 2,2 μx
xxxxxxxxxxxx bakterie (pneumokoka) Streptococcus xxxxxxxxxx&xxxx;xxxxxxxx 22X1,2&xxxx;2,2 μx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx)&xxxx;Xxxxxxxxxxxxx xxxxxxxxxx&xxxx;xxxxxxxx 23X1,2&xxxx;2,2 μg
polysacharid xxxxxxxx (xxxxxxxxxx)&xxxx;Xxxxxxxxxxxxx pneumoniae sérotypu 33F1,2 2,2 μx
1&xxxx;Xxxxxxxxxx x xxxxxx xxxxxxxxx CRM197 (přibližně 51 μx xx xxxxx)
2&xxxx;Xxxxxxxxxx xx xxxxxxxxxxx xxxxxxx (0,125 xx xxxxxxx xx dávku)
NEBO
1cha) xxxxxxxxxxx xxxxxxxx látka xxxxx xxxxxxxxxxxxx xxxxxxxx
1 dávka (0,5 xx) xxxxxxxx:
Xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 31&xxxx;4 μx
Xxxxxxxxxxxx xxxxxxxx (pneumokoka) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 6X1&xxxx;4 μx
Xxxxxxxxxxxx bakterie (xxxxxxxxxx) Streptococcus xxxxxxxxxx xxxxxxxx 7X1&xxxx;4 μx
Xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 81&xxxx;4 μx
Xxxxxxxxxxxx bakterie (pneumokoka) Xxxxxxxxxxxxx pneumoniae xxxxxxxx 9X1&xxxx;4 μx
Xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 10A1 4 μg
Polysacharid xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 11X1&xxxx;4 μx
Xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 12X1&xxxx;4 μg
Polysacharid xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx pneumoniae xxxxxxxx 15A1 4 μg
Polysacharid xxxxxxxx (pneumokoka) Streptococcus xxxxxxxxxx z xxXXx15X (xx-X-xxxxxxxxxxx xxxxxxx 15X)1&xxxx;4 μx
Xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx pneumoniae sérotypu 16X1&xxxx;4 μg
Polysacharid bakterie (xxxxxxxxxx) Streptococcus xxxxxxxxxx xxxxxxxx 17X1&xxxx;4 μx
Xxxxxxxxxxxx xxxxxxxx (pneumokoka) Streptococcus xxxxxxxxxx xxxxxxxx 19A1 4 μx
Xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 20X1&xxxx;4 μx
Xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Streptococcus pneumoniae xxxxxxxx 22X1&xxxx;4 μg
Polysacharid xxxxxxxx (xxxxxxxxxx) Streptococcus xxxxxxxxxx xxxxxxxx 23X1&xxxx;4 μx
Xxxxxxxxxxxx xxxxxxxx (pneumokoka) Xxxxxxxxxxxxx pneumoniae sérotypu 23X1&xxxx;4 μx
Xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 24X1&xxxx;4 μx
Xxxxxxxxxxxx xxxxxxxx (pneumokoka) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 311&xxxx;4 μx
Xxxxxxxxxxxx xxxxxxxx (pneumokoka) Xxxxxxxxxxxxx xxxxxxxxxx sérotypu 33X1&xxxx;4 μg
Polysacharid bakterie (xxxxxxxxxx) Streptococcus xxxxxxxxxx xxxxxxxx 35B1 4 μg
1 Konjugován x proteinovým xxxxxxx XXX197. XXX197&xxxx;xx xxxxxxxxx xxxxxx xxxxxxxxxxxx toxinu (xxxxxxxxxxxxx z xxxxxxxx Xxxxxxxxxxxxxxx diphtheriae X7) xxxxxxxxxxxxx exprimovaný v xxxxxxxx Xxxxxxxxxxx fluorescens.
NEBO
1chb) xxxxxxxx látky xxxxx xxxxxxxxxxxxx xxxxxxxx xxxxxxxxx x sekvenčním xxxxxxxx:
1xxxx) xxxxxxxxxxx xxxxxxxx látka xxxxxxxx:
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 11,2&xxxx;xxxxxxxxxxxxxxx 2,0 mikrogramů
Streptococci xxxxxxxxxx xxxxxxxx 31,2&xxxx;xxxxxxxxxxxxxxx 2,0 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 41,2&xxxx;xxxxxxxxxxxxxxx 2,0 xxxxxxxxxx
Xxxxxxxxxxxx pneumoniae xxxxxxxx 51,2&xxxx;xxxxxxxxxxxxxxx 2,0 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 6X1,2&xxxx;xxxxxxxxxxxxxxx 2,0 mikrogramů
Streptococci xxxxxxxxxx xxxxxxxx 6X1,2&xxxx;xxxxxxxxxxxxxxx 4,0 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 7X1,2&xxxx;xxxxxxxxxxxxxxx 2,0 mikrogramů
Streptococci xxxxxxxxxx xxxxxxxx 9V1,2 polysaccharidum 2,0 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 141,2&xxxx;xxxxxxxxxxxxxxx 2,0 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 18X1,2&xxxx;xxxxxxxxxxxxxxx 2,0 mikrogramů
Streptococci xxxxxxxxxx xxxxxxxx 19X1,2&xxxx;xxxxxxxxxxxxxxx 2,0 xxxxxxxxxx
Xxxxxxxxxxxx pneumoniae xxxxxxxx 19X1,2&xxxx;xxxxxxxxxxxxxxx 2,0 xxxxxxxxxx
Xxxxxxxxxxxx pneumoniae xxxxxxxx 22X1,2&xxxx;xxxxxxxxxxxxxxx 2,0 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 23X1,2&xxxx;xxxxxxxxxxxxxxx 2,0 mikrogramů
Streptococci pneumoniae xxxxxxxx 33X1,2&xxxx;xxxxxxxxxxxxxxx 2,0 xxxxxxxxxx
1&xxxx;Xxxxxxxxxx x xxxxxxxxxxx xxxxxxx XXX197. XXX197&xxxx;xx xxxxxxxxx mutace xxxxxxxxxxxx xxxxxx (pocházejícího z Corynebacterium xxxxxxxxxxx&xxxx;X7) xxxxxxxxxxxxx xxxxxxxxxxxxx x&xxxx;Xxxxxxxxxxx xxxxxxxxxxx.
2&xxxx;Xxxxxxxxxx na xxxxxxxx xxxxxxxxxxx hlinitý.
A
1chbb) xxxxxxxxxxxxxxx očkovací xxxxx xxxxxxxx:
xx 25 mikrogramech xxxxxxxxxxxxx 23 xxxxxxxxxxxxxx xxxxxxxxxxxxxxxxx xxxxxxxx: 1, 2, 3, 4, 5, 6X, 7F, 8, 9X, 9V, 10X, 11X, 12X, 14, 15B, 17X, 18X, 19F, 19X, 20, 22X, 23X, 33X.
XXXX
1xxx) xxxxxxxx látky xxxxx pneumokokovým xxxxxxxx xxxxxxxxx x sekvenčním xxxxxxxx:
1xxxx) xxxxxxxxxxx xxxxxxxx xxxxx xxxxxxxx:
Xxxxxxxxxxxx pneumoniae xxxxxxxxxxxxxxx xxxxxxxxx 11 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 31 2,2 µg
Streptococci xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 41&xxxx;2,2 µx
Xxxxxxxxxxxx pneumoniae xxxxxxxxxxxxxxx xxxxxxxxx 51 2,2 µx
Xxxxxxxxxxxx pneumoniae xxxxxxxxxxxxxxx xxxxxxxxx 6X1&xxxx;2,2 µg
Streptococci xxxxxxxxxx polysaccharidum xxxxxxxxx 6X1&xxxx;4,4 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 7X1&xxxx;2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 9V1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 141&xxxx;2,2 µg
Streptococci pneumoniae xxxxxxxxxxxxxxx xxxxxxxxx 18X1&xxxx;2,2µ x
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19A1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19X1&xxxx;2,2 µx
Xxxxxxxxxxxx pneumoniae xxxxxxxxxxxxxxx xxxxxxxxx 23X1&xxxx;2,2 µx
1&xxxx;Xxxxxxxxxx s xxxxxx xxxxxxxxx XXX197&xxxx;x xxxxxxxxxx xx xxxxxxxxxxx xxxxxxx (0,125 xx xxxxxxx).
X
1xxxx) xxxxxxxxxxxxxxx xxxxxxxx látka xxxxxxxx:
xx 25 xxxxxxxxxxxx xxxxxxxxxxxxx 23 pneumokokových xxxxxxxxxxxxxxxxx sérotypů: 1, 2, 3, 4, 5, 6X, 7X, 8, 9X, 9X, 10X, 11X, 12F, 14, 15B, 17X, 18X, 19F, 19X, 20, 22X, 23X, 33X.
1x) očkovací xxxxx xxxxx záškrtu, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, dětské xxxxxxxx xxxxx (inaktivovaná xxxxx):
Xxxxx xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx1&xxxx;- ne xxxx xxx 2 xxxxxxxxxxx xxxxxxxx (XX) (2,5 Xx)
Xxxxxx xxxxxxxxxx1 -&xxxx;xx méně než 20 xxxxxxxxxxxxx jednotek (XX) (5 Xx)
Xxxxxxxxxxx xxxxxxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxxx1 -&xxxx;8 mikrogramů
Pertussis haemagglutinum xxxxxxxxxxxx1&xxxx;- 8 mikrogramů
Pertaktin1 2,5 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx inactivatum:
typus 1 (xxxx Xxxxxxx)2&xxxx;40 X xxxxxxxx xxxxxxxx
xxxxx 2 (kmen XXX-1)2&xxxx;8 X xxxxxxxx xxxxxxxx
xxxxx 3 (xxxx Xxxxxxx)2&xxxx;32 X xxxxxxxx xxxxxxxx
1&xxxx;xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxxx xxxxxxx (Xx(XX)3) 0,3 xxxxxxxxx Xx3+&xxxx;x xxxxxxxxxxx xxxxxxx (XxXX4) 0,2 xxxxxxxxx Xx3+
2&xxxx;xxxxxxxxx xx XXXX buňkách
NEBO
1ia) xxxxxxxx xxxxx proti záškrtu, xxxxxxxx xxxxx (acelulární xxxxx), xxxxxx, xxxxxx xxxxxxxx obrně (inaktivovaná xxxxx):
Xxxxx xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx xxxxxxxxx 2 XX1&xxxx;(2 Xx)
Xxxxxx anatoxinum minimálně 20 XX1&xxxx;(5 Lf)
Pertusové xxxxxxxx:
Xxxxxxxxx anatoxinum 2,5 xxxxxxxxxx
Xxxxxxxxx haemagglutininum xxxxxxxxxxxx 5 mikrogramů
Pertactinum 3 xxxxxxxxxx
Xxxxxxxx, typi 2 xx 3 5 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx (xxxxxxxxxxx)2
xxxxx 1 (Xxxxxxx) 29 X jednotek antigenu3
typus 2 (XXX1) 7 X xxxxxxxx xxxxxxxx3
xxxxx 3 (Xxxxxxx) 26 X xxxxxxxx xxxxxxxx3
Xxxxxxxxxxx xx xxxxxxxxxxx hlinitý 1,5 xx (0,33 xx Al3+)
1 Jako xxxxxx xxxxxxx xxxxxxxxx xxxxxxxxxxxxx (x = 0,95) xxxxxxxx xxxxxx xxxxx xxxxx xxxxxxxxx v Xxxxxxxxx lékopisu.
2 Kultivováno xx Xxxx xxxxxxx.
3&xxxx;&xxxx;Xxxx xxxxxxxx xxxxxxxx xxxx xxxxx xxxxxx jako xx, xxxxx xxxx dříve xxxxxxxxx xxxx 40-8-32 X xxxxxxxx antigenu xxx xxxxx typu 1, 2 x 3, xxx xxxxxx xxxxx vhodnou xxxxxxxxxxxxxx xxxxxxx.
* Jako spodní xxxxxxx xxxxxxxxx spolehlivosti (x = 0,95) xxxxxxxx měřené xxxxx xxxxx xxxxxxxxx x Xxxxxxxxx xxxxxxxx.
** Kultivováno xx Xxxx buňkách.
1j) xxxxxxxx xxxxx xxxxx xxxxxxxxxxx (BCG vakcína)
1k) očkovací xxxxx xxxxx xxxxxx xxxxxxxxxx X xxx xxxxx xxxxxxxx do xxxxxxxxxxxx xxxxxxxx:
Xxxxx xxxxx (0,5 ml) vakcíny xxxxxxxx:
Xxxxxxxxx xxxxxxxxx hepatitidis X1,2,3&xxxx;- 20 xxxxxxxxxx
1&xxxx;xxxxxxxxxx xx XX04X xxxxxxxxxx: - 3-X-xxxxxx-4′-xxxxxxxxxxxx-xxxxx X (XXX)2&xxxx;50 mikrogramů
2 adsorbovaný xx xxxxxxxxxxx xxxxxxx (xxxxxx 0,5 xxxxxxxxx Xx3+)
3&xxxx;xxxxxxxx xx xxxxxxx xxxxxxxxxxxx xxxxx&xxxx;(Xxxxxxxxxxxxx xxxxxxxxxx)&xxxx;xxxxxxxxxxxxx DNA xxxxxxxxxxx.
2. Xxxxxxxxx složení xxxxxxxxxx xxxxx pro xxxxxxxx očkování
2a) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X xx xxxxxxx pro xxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxx tegiminis xxxxxxxxxxx B - 20 xxxxxxxxxx
2x) očkovací xxxxx xxxxx xxxxxxxxx
2x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X xx xxxxxxx xxx xxxxxxx:
Xxxxx xxxxx obsahuje:
Hepatitis X virus xxxxxxxxxxx
2x) xxxxxxxx xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx:
1 xxxxx xxxxxxxxxxxxxxx xxxxxxx (0,5 ml) xxxxxxxx:
Xxxxxxxxxxx xxxxx xxxxxxxxxx1&xxxx;(Xxxxxxx) xxx. 103,0&xxxx;xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
Xxxxxxxxxxx xxxxx xxxxxxxxxx1&xxxx;(XXX 4385) xxx. 103,7&xxxx;xxxxxxxx dávka xxx buněčnou kulturu503
Rubeolae xxxxx xxxxxxxxxx2&xxxx;(Xxxxxx XX 27/3) xxx. 103,0 infekční xxxxx pro buněčnou xxxxxxx503
1&xxxx;xxxxxxxxx xx xxxxxxx xxxxxxxx xxxxxx
2&xxxx;xxxxxxxxx na xxxxxxxx diploidních xxxxxxx (XXX-5)
3&xxxx;50% xxxxxxxx dávka xxxxxxx kultury
NEBO
2da) xxxxxxxx xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx x zarděnkám
Po xxxxxxxxxx obsahuje xxxxx xxxxx (0,5 xx):
Xxxxx xxxxxxxxxxx1&xxxx;xxxxx xxxxxxxxxx (xxxx Xxxxxx’ Edmonston) ne xxxx xxx 1x103 CCID50*
Virus xxxxxxxxxxx1&xxxx;xxxxx xxxxxxxxxx (kmen Xxxxx Xxxx™, hladina X) ne xxxx xxx 12,5x103 CCID50*
Virus rubeolae2 vivum xxxxxxxxxx (xxxx Xxxxxx XX 27/3) ne xxxx než 1x103&xxxx;XXXX50*
* 50% xxxxxxxx xxxxx xxxxxxx kultury
1 vyrobeno xx xxxxxxx kuřecích xxxxxx.
2&xxxx;xxxxxxxx xx xxxxxxxx xxxxxxxxxxx xxxxxxxx WI-38 xxxxxxxxxxxxx.
3. Xxxxxxxxx složení očkovacích xxxxx xxx mimořádná xxxxxxxx
3x) očkovací xxxxx xxxxx xxxxxx xxxxxxxxxx X xx xxxxxxx xxx dospělé:
Virus xxxxxxxxx X inactivatum
3b) očkovací xxxxx xxxxx virové xxxxxxxxxx X xx xxxxxxx xxx xxxx:
Xxxxx xxxxxxxxx A xxxxxxxxxxx
3x) xxxxxxxx xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx:
1 dávka xxxxxxxxxxxxxxx xxxxxxx (0,5 ml) xxxxxxxx:
Xxxxxxxxxxx xxxxx xxxxxxxxxx1&xxxx;(Xxxxxxx) xxx. 103,0&xxxx;xxxxxxxx xxxxx xxx xxxxxxxx kulturu503
Parotitidis xxxxx attenuatum1 (RIT 4385) xxx. 103,7 infekční xxxxx xxx buněčnou xxxxxxx503
Xxxxxxxx xxxxx attenuatum2 (Wistar RA 27/3) xxx. 103,0 infekční xxxxx xxx buněčnou xxxxxxx503
1&xxxx;xxxxxxxxx xx xxxxxxx xxxxxxxx embryí
2 pomnoženo xx xxxxxxxx xxxxxxxxxxx xxxxxxx (XXX-5)
3&xxxx;50% xxxxxxxx dávka xxxxxxx xxxxxxx
XXXX
3xx) očkovací xxxxx proti xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx
Xx xxxxxxxxxx xxxxxxxx xxxxx xxxxx (0,5 xx):
Xxxxx xxxxxxxxxxx1&xxxx;xxxxx attenuatum (xxxx Xxxxxx’ Edmonston) xx xxxx xxx 1x103&xxxx;XXXX50*
Xxxxx xxxxxxxxxxx1&xxxx;xxxxx xxxxxxxxxx (kmen Xxxxx Lynn™, xxxxxxx X) xx xxxx xxx 12,5x103 CCID50*
Virus xxxxxxxx2&xxxx;xxxxx xxxxxxxxxx (kmen Wistar XX 27/3) xx xxxx než 1x1103 CCID50*
* 50% infekční dávka xxxxxxx xxxxxxx
1&xxxx;xxxxxxxx xx xxxxxxx kuřecích embryí.
2 vyrobeno xx lidských xxxxxxxxxxx xxxxxxxx XX-38 xxxxxxxxxxxxx.
&xxxx;
Xxxxxxx:
xxxx. XXXx. Válek, XXx., XXX, EBIR, x. x.
Xxxxxxxxx
Xxxxxx xxxxxxx č. 528/2025 Xx. xxxxx xxxxxxxxx xxxx 12.12.2025.
Xx xxx uzávěrky xxxxxx xxxxxxx xxxxx xxxxx xx xxxxxxxxx.
Xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx jiných xxxxxxxx xxxxxxxx x xxxxxxxx xxxx aktualizováno, xxxxx xx xxxx xxxxxx xxxxxxxxx xxxxx xxxxx uvedeného právního xxxxxxxx.